Whitlow Ricci S 4

What Happened
Whitlow Ricci, Chief Operating Officer of MIMEDX Group, was granted two equity awards on March 4, 2026: 74,163 restricted shares and a 62,068-share derivative award. Both grants are reported at $0.00 per share on the Form 4, indicating compensation awards rather than open-market purchases.

Key Details

• Transaction date: 2026-03-04. Form 4 filed: 2026-03-06 (appears timely).
• Awards: 74,163 restricted shares (listed as a restricted stock grant) and 62,068 shares listed as a derivative/award.
• Price: $0.00 per share for both items as reported (typical for grants).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: F1 — restricted stock vests fully on the third anniversary subject to continued employment; F2 — the derivative award (options) vests 25% on each anniversary (four-year vesting), subject to continued employment.
• Transaction code: A = Grant/Award. No indication these shares were sold or that options were exercised at grant.

Context
These awards are standard executive compensation and represent potential future ownership as vesting conditions are met; they do not reflect an open-market purchase or sale today. The option-style award will vest over multiple anniversaries (per F2) and would only convert into tradable shares if/when vested and exercised. For investors, grants increase potential future share dilution and are routine for management retention; they are informative about compensation but do not by themselves signal a buy or sell decision.